Close
Help




JOURNAL

Biomarkers in Cancer

CD151—A Striking Marker for Cancer Therapy

Submit a Paper


Biomarkers in Cancer 2015:7 7-11

Review

Published on 22 Mar 2015

DOI: 10.4137/BIC.S21847


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Biomarkers in Cancer

Abstract

Cluster of differentiation 151 (CD151) is a member of the mammalian tetraspanin family, which is involved in diverse functions such as maintaining normal cellular integrity, cell-to-cell communication, wound healing, platelet aggregation, trafficking, cell motility and angiogenesis. CD151 also supports de novo carcinogenesis in human skin squamous cell carcinoma (SCC) and tumor metastasis. CD151 interacts with α3β1 and α6β4 integrins through palmitoylation where cysteine plays an important role in the association of CD151 with integrins and non-integrin proteins. Invasion and metastasis of cancer cells were diminished by decreasing CD151 association with integrins. CD151 functions at various stages of cancer, including metastatic cascade and primary tumor growth, thus reinforcing the importance of CD151 as a target in oncology. The present review highlights the role of CD151 in tumor metastasis and its importance in cancer therapy.



Downloads

PDF  (1.56 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Biomarkers in Cancer
Publishing with Libertas Academica is unlike any other experience I have had. The process was totally up-to-date and responses to my queries received prompt replies, the whole time. These two features alone are worth the whole experience.
Dr Noel Pabalan (Angeles University Foundation, Angeles City, Philippines)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube